The cloud is not only a competitive advantage but a new status quo. In fact, the healthcare cloud computing market is expected to grow to $120.6 billion by 2029, up from $53.8 billion in 2024.
As healthcare organizations migrate to the cloud or improve their cloud posture, it’s important to remember that transformation comes with opportunities and challenges alike.
The cloud frees companies from being held back by traditional, outdated systems and three-to-five-year hardware refresh
Read More
The NP/PA Factor: Why Advanced Practice Providers Are Essential for Life Sciences in 2025
For decades, life sciences companies have centered their marketing efforts on physicians, assuming they hold the greatest influence over prescribing and treatment decisions. However, the healthcare landscape has shifted dramatically. Nurse practitioners (NPs) and physician assistants/associates (PAs) are not just supporting players, they are primary prescribers shaping patient care across nearly every therapeutic area.
This shift is finally being recognized across the industry. According to
Read More
Scalability in Revenue Cycle: Building a Flexible Model for Sustainable Growth
The demands on revenue cycle management (RCM) today are unrelenting. Healthcare providers are navigating ongoing regulatory shifts while financial constraints and growing patient volumes place immense pressure. The average internal cost of running an RCM operation has increased from 4% to 5%, even with the advances in technology and automation. To be successful, providers must maintain efficiency while delivering quality care.
With this current landscape, RCM must be built for adaptability;
Read More
Critical Role of Transitions of Care in Medicare Advantage Success
The Medicare Advantage (MA) market is at a tipping point, with more than half of all seniors enrolled in an MA plan for their healthcare. Utilization of services is skyrocketing and the Centers for Medicare and Medicaid Services (CMS) has increased pressure to deliver supplemental benefits in a high-quality, low-cost and reportable manner.
As enrollment continues to grow, how health plans are paid — and how much —will be central to the debate over the efficiency and sustainability of
Read More
Rural Healthcare Challenges: How AI & Telemedicine Can Improve Access
With tight-knit communities, strong traditions, and a deep sense of resilience, rural America is a key piece of our nation’s fabric. Yet, for many people living in these areas—one in five Americans—getting basic healthcare can be an uphill battle. Limited hospital options, provider shortages, and economic struggles can make what should be routine checkups feel like monumental tasks.
Ensuring equitable access to care across the nation is a critical goal. While technology offers
Read More
Neuro-Symbolic AI Brings Precision to Healthcare Risk Adjustment
A conversation with RAAPID founder and CEO Chetan Parikh reveals how his company's purpose-built AI platform is transforming risk adjustment in healthcare. The Series A investment from Microsoft's M12 venture fund marks a significant milestone in the organization's mission to accelerate healthcare's transition to value-based care.
"Our vision is to develop and deploy advanced healthcare AI technologies that empower healthcare workers to deliver quality & affordable care," Parikh explains.
Read More
Streamlining Hospital Discharge: How Technology Can Solve Readmission Challenges
Hospital discharge is a make-or-break moment in patient care, yet it is one of the most challenging aspects of healthcare delivery. A poorly executed discharge can result in confusion, medication errors, and, ultimately, costly hospital readmissions. For healthcare organizations focused on value-based care, improving discharge procedures is essential for enhancing patient outcomes, ensuring seamless care transitions, and reducing financial costs.
The good news is that hospital readmissions
Read More
AI Optimizing Payer-Provider Relations: From Adversarial to Collaborative
Payer-provider relations are undergoing a major shift. The classic adversarial battles in the fee-for-service world are gradually giving way to capitated plans with more win-win incentives. The reality is that providers and payers famously have to live in the “two canoes” world, with one foot in volume-based revenue and the other foot in value-based revenue.
As one can see, there is extraordinary information and calculation needed to optimize revenues on both sides. The good news
Read More
Cycle Time is the New Currency of Drug Development
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive, and failure rates remain high. Studies estimate the total cost to develop a new drug is between $300 million and nearly $4.5 billion. Meanwhile, clinical trial cycle times continue to lengthen – significantly impacting overall drug development timelines. Clinical trials are increasingly
Read More
Closing the Affordability Gap: How Automation is Advancing Biosimilar Adoption
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients either skip or delay their medication due to cost concerns, a challenge that is widespread throughout the U.S. The financial burden is even greater for those managing multiple chronic conditions, where prescription costs can quickly add up to unmanageable amounts.
Despite the financial strain,
Read More
